What is the incidence of clinically significant coronary calcification in young adults (18‑30 years) with a history of Kawasaki disease, especially those with persistent large or giant aneurysms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Incidence of Significant Coronary Calcification in Young Adults with Kawasaki Disease History

Young adults with a history of Kawasaki disease and persistent large or giant coronary aneurysms have an extremely high incidence of significant coronary calcification, approaching 80-95%, while those with normal coronary arteries during acute disease have essentially zero risk of calcification.

Incidence Based on Coronary Artery Status During Acute Phase

Patients with Giant or Persistent Aneurysms

  • Approximately 79-95% of patients with coronary aneurysms develop detectable coronary artery calcification (CAC) when imaged ≥9 years after acute Kawasaki disease 1, 2
  • In one cohort of 24 subjects with persistent coronary aneurysms (median age 19.5 years, median 15.1 years post-KD), 19 of 24 (79%) had detectable CAC, with median calcium volume of 542 mm³ (range 17-8,218 mm³) 1
  • A separate study found that 10 of 14 patients (71%) with coronary aneurysms had coronary calcification when imaged at median 14.8 years post-acute illness 2
  • All patients with coronary aneurysms associated with stenosis and/or occlusion had identifiable coronary calcification on plain chest X-ray 3

Patients with Normal or Transiently Dilated Coronaries

  • Zero incidence: All 100 subjects with coronary arteries classified as normal during acute KD had zero CAC on follow-up imaging 1
  • Near-zero incidence: Only 1 of 12 patients (8%) with transiently dilated coronaries during acute phase developed any calcification 2
  • All 10 subjects with persistently dilated (but not aneurysmal) coronaries had zero CAC 1

Temporal Relationship and Severity

Timing of Calcification Development

  • Coronary calcification occurs late in the disease course, typically many years after the acute illness 2
  • The degree of coronary artery dilation after Kawasaki disease correlates with the risk of future calcification 4
  • Calcification severity ranges from mild to severe, with some patients developing massive calcification (up to 8,218 mm³ calcium volume) 1

Clinical Significance of Calcification

  • The presence of CAC is strongly associated with stenotic lesions: all significant stenotic lesions were concomitant with calcification 3
  • Heavy calcification of the inner layer can prevent normal luminal development and produce significant narrowing (up to 50% stenosis) as patients grow into adulthood 5
  • In a prospective cohort pilot study, patients with Kawasaki disease with residual coronary abnormalities showed CT evidence of CAC, and the presence of CAC may be predictive of sudden death 4

Diagnostic Performance of CAC Screening

Sensitivity and Specificity

  • For subjects imaged ≥9 years after acute KD, CAC presence had 95% sensitivity and 100% specificity for detecting coronary artery abnormalities (defined as aneurysm and/or stenosis) 1
  • Multislice spiral CT demonstrated 100% sensitivity for detecting coronary artery aneurysms and 87.5% sensitivity for significant stenoses/occlusions in adolescents and young adults with KD 6
  • False-positive results occurred in 5 arteries due to severe calcification and in 2 due to cardiac motion artifact, yielding 92.5% specificity 6

Clinical Implications and Surveillance Strategy

Risk Stratification Algorithm

  • Young adults (18-30 years) with documented giant aneurysms (≥8 mm) or persistent large aneurysms during acute KD should be assumed to have very high risk (approximately 80-95%) of significant coronary calcification 1, 2
  • Those with Z-score ≥10 and absolute dimension ≥8 mm had 48% incidence of adverse outcomes (catheter intervention, MI, death) 4
  • Patients with normal coronary arteries during acute phase can be reassured of essentially zero risk of late calcification 1, 2

Screening Recommendations

  • Plain chest X-ray with specific search for coronary calcification is a simple, inexpensive, low-dose method that easily identifies KD patients at risk for serious coronary stenosis 3
  • When calcification is detected on chest X-ray, closer tracking of coronary artery patency is warranted via other imaging techniques 3
  • CAC scanning may be a useful tool to screen patients with remote history of KD or suspected KD with unknown coronary artery status 1, 2

Management of Detected Calcification

  • The presence of coronary calcification in young adults with KD history indicates high risk for progressive stenotic lesions and warrants aggressive surveillance 4
  • Coronary calcification presents particular challenges for acute percutaneous interventions, relating to potential underestimation of true luminal dimensions and difficulty with stent deployment 4
  • IVUS imaging is essential to demonstrate true luminal dimensions and improve stent deployment in these patients 4

Common Pitfalls to Avoid

  • Do not assume that absence of symptoms indicates absence of significant coronary disease: MI in young KD patients can be clinically silent or present with atypical symptoms 4
  • Do not rely solely on angiographic "normalization": vessels that appear angiographically normal after aneurysm regression may have significant wall thickening, calcification, and functional abnormalities on IVUS 4
  • Do not underestimate stenosis severity in heavily calcified vessels: poor image quality and severe calcifications can lead to overestimation or underestimation of stenosis severity on coronary CTA 7
  • Do not delay evaluation in patients with giant aneurysms: the highest risk of MI occurs in patients with giant aneurysms (≥8 mm), and serial stress tests with myocardial imaging are mandatory 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.